Dhampur Bio Organics Proposes ₹50 Crore Open-Market Buyback
Key highlights
- Dhampur Bio Organics proposed an open-market buyback of up to ₹50 crore on November 14, 2026.
- The maximum buyback price is ₹200 per equity share, with an indicative limit of 25 lakh shares.
- The proposed 25 lakh shares represent up to 3.76% of paid-up equity capital.
- Dhampur Bio Organics reported Q2 FY27 profit after tax of ₹26.62 crore from continuing operations.
powered by IRIS

Dhampur Bio Organics Limited has proposed an open-market buyback of up to ₹50 crore at a maximum price of ₹200 per equity share, potentially covering up to 25 lakh shares or 3.76% of its paid-up equity capital. The November 14, 2026 proposal requires shareholder approval before any purchases can begin.
Know Dhampur Bio Organics inside out
Results, valuation, peers and who's buying, in one view.
What has Dhampur Bio Organics approved?
Dhampur Bio Organics approved a proposal to buy back fully paid-up equity shares with a face value of ₹10 each, for an aggregate amount not exceeding ₹50 crore. The board approved the proposal at its meeting held on November 14, 2026, alongside the audited standalone and consolidated financial results for the quarter and half year ended September 30, 2026.
The proposed buyback will be conducted through the open-market route on the stock exchanges where the company’s shares are listed. The company has set ₹200 per share as the maximum buyback price and indicated that the maximum number of shares that could be acquired is 25 lakh. This quantity represents up to 3.76% of its paid-up equity capital.
The ₹50 crore amount is the upper limit rather than a confirmed purchase value. The filing also specifies a minimum buyback size of ₹37.50 crore, equal to 75% of the maximum size. The final number of shares acquired will depend on the purchase price and the execution of the buyback within the approved terms.
Why is shareholder approval still required?
The buyback is not yet effective because Dhampur Bio Organics must obtain approval from its members through a special resolution. The company will seek this approval through a postal ballot, including remote e-voting, before starting any market purchases.
The board approved the postal-ballot notice in the same meeting. However, the filing does not provide the postal-ballot schedule, record date, voting dates, or a buyback commencement date. Dhampur Bio Organics said the process, timelines and other required details for the postal ballot will be communicated in due course.
The company also said it will issue a public announcement with the buyback process, timeline and statutory details in accordance with the SEBI (Buy-back of Securities) Regulations, 2018. Until the shareholder resolution and applicable regulatory requirements are completed, the board approval remains a proposal rather than an authorisation for immediate purchases.
Who can participate in the proposed buyback?
Dhampur Bio Organics has proposed to buy shares from public shareholders, excluding promoters, the promoter group and persons in control. Eligible public shareholders may sell shares through the stock exchanges if the buyback is approved and subsequently opened under the announced process.
An open-market buyback differs from a tender offer because shares are acquired through stock-exchange transactions rather than through a fixed entitlement offered to every eligible holder. The maximum price of ₹200 sets the ceiling at which the company may purchase shares, but it does not guarantee that shares will be bought at that price.
For investors, the key disclosed limits are the maximum ₹50 crore outlay, the ₹200 per-share ceiling and the 25 lakh-share indicative maximum. The actual volume acquired can be lower than the indicative maximum because the final quantity depends on market purchases and the price at which transactions take place.
Got a follow-up? Ask IRIS
What else did the board decide on November 14?
Along with the buyback proposal, Dhampur Bio Organics approved its audited standalone and consolidated results for the September 2026 quarter and half year. The company reported profit after tax of ₹26.62 crore from continuing operations for the September quarter of FY27.
The board also appointed a cost auditor for financial year 2026-27 to fill a casual vacancy. This governance decision was announced with the results, buyback proposal and postal-ballot notice as part of the board-meeting outcome filed on the exchanges.
How does the proposal matter for investors and the company?
The proposed transaction establishes the capital amount and price ceiling that Dhampur Bio Organics may use for repurchasing shares, subject to the required vote. A completed buyback can reduce the number of shares outstanding to the extent shares are acquired, but the company has not disclosed a final quantity because the proposal is capped by both the monetary limit and maximum price.
The announcement also provides clarity that the process will follow the SEBI buyback framework and will be executed through the stock exchanges. Investors will need to wait for the postal-ballot communication and subsequent public announcement for dates, operational instructions and other statutory details.
The board’s approval came with the company’s September-quarter results, making the ₹26.62 crore profit from continuing operations the latest financial figure disclosed in the announcement. No buyback commencement date, record date or completed share purchase has been announced in the available filing.
Conclusion
Dhampur Bio Organics has initiated a proposal for an open-market share buyback worth up to ₹50 crore, with a maximum purchase price of ₹200 per share and an indicative cap of 25 lakh shares. The plan remains conditional on a shareholder special resolution and other applicable approvals, so it does not currently permit immediate purchases.
The next disclosed steps are the postal-ballot process, remote e-voting by shareholders and the public announcement required under SEBI regulations. Investors should watch for these communications, which are expected to provide the timetable and operational terms for the proposed buyback.


